Clinical Trial Update: Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome

View source ↗

Summary

A clinical trial update indicates recruitment is ongoing to study the impact of Highly Effective Modulator Therapy on the cystic fibrosis microbiome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Highly Effective Modulator Therapy

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Cystic Fibrosis | Status: RECRUITING